Actually I would like the ETAH business model better than CBMG's. CBMG has phase 1 clinical trials which means no revenue probably for years. ETAH sounds like a stem cell bank with recurring revenues.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.